thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38708078-04D1804A-356D-4345-AF3E-77F509A19449
Q38708078-04D1804A-356D-4345-AF3E-77F509A19449
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38708078-04D1804A-356D-4345-AF3E-77F509A19449
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.
P2860
Q38708078-04D1804A-356D-4345-AF3E-77F509A19449
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38708078-04D1804A-356D-4345-AF3E-77F509A19449
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6175cb46552a39019bd28f2da948c6ba13343750
P2860
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin.